• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPHER METHKE GMBH & CO. KG PROGAV 2.0 VALVE; HYDROCEPHALUS VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPHER METHKE GMBH & CO. KG PROGAV 2.0 VALVE; HYDROCEPHALUS VALVES Back to Search Results
Model Number FX410T
Device Problem Obstruction of Flow (2423)
Patient Problem Failure of Implant (1924)
Event Date 11/23/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional "1y 7m po valve is not adjustable, there is blockage.Explanted.".
 
Manufacturer Narrative
The valve was received submerged in an unidentified liquid in a plastic container.No deformation or damage of the valve were detected during the visual inspection.The permeability test shown that the progav 2.0 valve is permeable.The progav 2.0 valve was tested and is not adjustable throughout the normal range.The braking functionality test has shown that the brake function is operational, however the braking force cannot be measured due to the non-adjustability of the valve.To test the opening pressure, we used (b)(6) computer controlled testing apparatus which stimulates a cerebrospinal fluid flow.The progav 2.0 valve is not operating within acceptance tolerances.We performed a visual inspection of the prosa 2.0 valve.No deformation or damage of the valve were detected during the visual inspection.Then we tested the permeability, adjustability, and opening pressure of the valve.The progav2.0 valve was permeable but could not be adjusted to all settings.Furthermore, the opening pressure was measured to be significantly less than the specified tolerance, indicating a tendency towards over drainage.Next we measured the brake functionally and braking force of the valve.The brake functionality operated as expected, however the brake force could not be measured due to the inability of the valve to hold a set pressure.Finally, we have dismantled the valve.Inside the prosa we have found a buildup of substance (likely protein).Based on our investigation, we confirm that the valve is non-adjustable, likely due to the deposits observed inside the valve.Furthermore, we have determined that instead of the claimed under drainage that the valve is operating in a state of over-drainage that the valve is operating in a state of over drainage.This could also be attributed to the deposits observed inside the valve.We can exclude a defect at the time of release.The valve met all specifications of the final inspections.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 VALVE
Type of Device
HYDROCEPHALUS VALVES
Manufacturer (Section D)
CHRISTOPHER METHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8157950
MDR Text Key130164007
Report Number3004721439-2018-00293
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 12/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/06/2021
Device Model NumberFX410T
Device Catalogue NumberFX410T
Device Lot Number20032484
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/26/2018
Distributor Facility Aware Date12/07/2018
Device Age2 YR
Date Manufacturer Received12/06/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age2 YR
Patient Weight11
-
-